These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 29661721)
1. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Zheng YZ; Liang L Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721 [TBL] [Abstract][Full Text] [Related]
2. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway. Ma N; Zhao Y Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer. Du J Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777 [TBL] [Abstract][Full Text] [Related]
4. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. Jiang HW; Li L; Jiang P; Wang YF Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947 [TBL] [Abstract][Full Text] [Related]
6. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis. Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102 [TBL] [Abstract][Full Text] [Related]
7. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer. Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423 [TBL] [Abstract][Full Text] [Related]
8. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway. Zhao LW; Yu AJ; Zhang YJ; Wang XC; Han B; Wang XH Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):55-64. PubMed ID: 31957818 [TBL] [Abstract][Full Text] [Related]
10. MiR-198 inhibits proliferation, invasion and migration of ovarian cancer cells by regulating the PI3K/Akt signaling pathway. Xiao H; Zheng Y; Chen J; Shen H Acta Biochim Pol; 2021 Jun; 68(4):673-677. PubMed ID: 34181826 [TBL] [Abstract][Full Text] [Related]
11. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
14. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells. Miao F; Zhang X; Cao Y; Wang Y; Zhang X BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922 [TBL] [Abstract][Full Text] [Related]
15. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer. Li D; Pan Y; Huang Y; Zhang P; Fang X Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957 [TBL] [Abstract][Full Text] [Related]
16. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms. Qi Y; Mo K; Zhang T Biomed Eng Online; 2021 Aug; 20(1):83. PubMed ID: 34399777 [TBL] [Abstract][Full Text] [Related]
17. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745 [TBL] [Abstract][Full Text] [Related]
18. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway. Zhu J; Hu H; Wang J; Yang Y; Yi P Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
20. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance. Liu T; Jin ZW; Li Y; Zhang G; Yang XY; Xu XM; Ma YC J Cancer Res Ther; 2022 Apr; 18(2):488-495. PubMed ID: 35645119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]